Ugur B, Schueder F, Shin J, Hanna M, Wu Y, Leonzino M
J Cell Biol. 2024; 223(12).
PMID: 39331042
PMC: 11451052.
DOI: 10.1083/jcb.202311189.
Kamano S, Ozawa D, Ikenaka K, Nagai Y
Int J Mol Sci. 2024; 25(16).
PMID: 39201619
PMC: 11354291.
DOI: 10.3390/ijms25168935.
Wang C, Liu H, Li X, Ma J, Gu Z, Feng X
NPJ Parkinsons Dis. 2024; 10(1):134.
PMID: 39043730
PMC: 11266557.
DOI: 10.1038/s41531-024-00722-1.
Schrder L, Peng W, Gao G, Wong Y, Schwake M, Krainc D
J Cell Biol. 2024; 223(5).
PMID: 38358348
PMC: 10868123.
DOI: 10.1083/jcb.202304042.
Ugur B, Schueder F, Shin J, Hanna M, Wu Y, Leonzino M
bioRxiv. 2024; .
PMID: 38187698
PMC: 10769246.
DOI: 10.1101/2023.12.18.572081.
More than meets the eye in Parkinson's disease and other synucleinopathies: from proteinopathy to lipidopathy.
Flores-Leon M, Outeiro T
Acta Neuropathol. 2023; 146(3):369-385.
PMID: 37421475
PMC: 10412683.
DOI: 10.1007/s00401-023-02601-0.
Enhancement of lysosome biogenesis as a potential therapeutic approach for neurodegenerative diseases.
Xue W, Zhang J, Li Y
Neural Regen Res. 2023; 18(11):2370-2376.
PMID: 37282455
PMC: 10360109.
DOI: 10.4103/1673-5374.371346.
-An Emerging Master Regulator of Autoimmunity and Neurodegeneration.
Pandey R, Bakay M, Hakonarson H
Int J Mol Sci. 2023; 24(9).
PMID: 37175930
PMC: 10179542.
DOI: 10.3390/ijms24098224.
Genetic Evidence for Endolysosomal Dysfunction in Parkinson's Disease: A Critical Overview.
Yahya V, Di Fonzo A, Monfrini E
Int J Mol Sci. 2023; 24(7).
PMID: 37047309
PMC: 10094484.
DOI: 10.3390/ijms24076338.
Inter-organellar Communication in Parkinson's and Alzheimer's Disease: Looking Beyond Endoplasmic Reticulum-Mitochondria Contact Sites.
Vrijsen S, Vrancx C, Del Vecchio M, Swinnen J, Agostinis P, Winderickx J
Front Neurosci. 2022; 16:900338.
PMID: 35801175
PMC: 9253489.
DOI: 10.3389/fnins.2022.900338.
ER-lysosome lipid transfer protein VPS13C/PARK23 prevents aberrant mtDNA-dependent STING signaling.
Hancock-Cerutti W, Wu Z, Xu P, Yadavalli N, Leonzino M, Tharkeshwar A
J Cell Biol. 2022; 221(7).
PMID: 35657605
PMC: 9170524.
DOI: 10.1083/jcb.202106046.
Lysosomal dysfunction in neurodegeneration: emerging concepts and methods.
Udayar V, Chen Y, Sidransky E, Jagasia R
Trends Neurosci. 2022; 45(3):184-199.
PMID: 35034773
PMC: 8854344.
DOI: 10.1016/j.tins.2021.12.004.
Animal Models of Autosomal Recessive Parkinsonism.
Bastioli G, Regoni M, Cazzaniga F, De Luca C, Bistaffa E, Zanetti L
Biomedicines. 2021; 9(7).
PMID: 34356877
PMC: 8301401.
DOI: 10.3390/biomedicines9070812.
Insights into VPS13 properties and function reveal a new mechanism of eukaryotic lipid transport.
Leonzino M, Reinisch K, De Camilli P
Biochim Biophys Acta Mol Cell Biol Lipids. 2021; 1866(10):159003.
PMID: 34216812
PMC: 8325632.
DOI: 10.1016/j.bbalip.2021.159003.
An Emerging Role for Phosphoinositides in the Pathophysiology of Parkinson's Disease.
Schechter M, Sharon R
J Parkinsons Dis. 2021; 11(4):1725-1750.
PMID: 34151859
PMC: 8609718.
DOI: 10.3233/JPD-212684.
Contribution of rare homozygous and compound heterozygous VPS13C missense mutations to dementia with Lewy bodies and Parkinson's disease.
Smolders S, Philtjens S, Crosiers D, Sieben A, Hens E, Heeman B
Acta Neuropathol Commun. 2021; 9(1):25.
PMID: 33579389
PMC: 7881566.
DOI: 10.1186/s40478-021-01121-w.
Targeted sequencing of Parkinson's disease loci genes highlights SYT11, FGF20 and other associations.
Rudakou U, Yu E, Krohn L, Ruskey J, Asayesh F, Dauvilliers Y
Brain. 2020; 144(2):462-472.
PMID: 33349842
PMC: 7940168.
DOI: 10.1093/brain/awaa401.
Role of VPS13, a protein with similarity to ATG2, in physiology and disease.
Ugur B, Hancock-Cerutti W, Leonzino M, De Camilli P
Curr Opin Genet Dev. 2020; 65:61-68.
PMID: 32563856
PMC: 7746581.
DOI: 10.1016/j.gde.2020.05.027.
Genetic perspective on the synergistic connection between vesicular transport, lysosomal and mitochondrial pathways associated with Parkinson's disease pathogenesis.
Smolders S, Van Broeckhoven C
Acta Neuropathol Commun. 2020; 8(1):63.
PMID: 32375870
PMC: 7201634.
DOI: 10.1186/s40478-020-00935-4.
Mutated ATP10B increases Parkinson's disease risk by compromising lysosomal glucosylceramide export.
Martin S, Smolders S, Van den Haute C, Heeman B, van Veen S, Crosiers D
Acta Neuropathol. 2020; 139(6):1001-1024.
PMID: 32172343
PMC: 7244618.
DOI: 10.1007/s00401-020-02145-7.
